Landmark Study Confirms No Increased Mortality risk from COVID-19 mRNA Vaccines
A thorough new study has found no evidence that mRNA COVID-19 vaccines increase the risk of long-term, all-cause mortality in France, directly challenging claims circulating within vaccine-skeptical communities. Published Thursday, December 4, the research offers a robust analysis of nearly 30 million individuals, providing critical data on the long-term safety profile of these widely used vaccines.
The study, conducted by the Epi-Phare group – a collaboration between the French Medicines Safety Agency (ANSM) and Health Insurance – examined health data from 2021 through 2025, encompassing the entire 18-59 age group. Researchers found a important disparity in mortality rates between vaccinated and unvaccinated individuals, with the vaccinated group experiencing a lower rate of death.
Specifically, 0.4% of vaccinated individuals died within four years of receiving their first vaccine dose, compared to 0.6% in the unvaccinated group. This translates to a 25% higher general mortality rate among those who remained unvaccinated. “We can say with a high degree of confidence that there is no increase in mortality risk after a Covid vaccine,” stated researcher Mahmoud Zureik, who supervised the study, to Agence France-Presse. He further noted that the findings “helps to close the misinformation conveyed around messenger RNA vaccines,” as reported by Le Monde.
While the study definitively refutes claims of increased mortality, researchers caution against interpreting the data as proof that vaccines reduce overall death rates. the observed difference in mortality could be attributed to a combination of factors, including the protective effects of vaccination and inherent differences in the demographics of vaccinated versus unvaccinated individuals – such as age, socioeconomic status, and underlying health conditions.
The research builds upon existing evidence supporting the safety and efficacy of COVID-19 vaccines. While rare, serious side effects – primarily cardiovascular issues like myocarditis and pericarditis – have been documented, these do not outweigh the benefits of vaccination for most age groups. In France, the Moderna vaccine is currently not recommended for young adults due to these concerns.
The study addresses a critical gap in understanding the long-term impact of mRNA vaccines.Vaccine skeptic circles have persistently promoted the idea that these vaccines have caused undetected fatalities, despite official data focusing on mortality directly linked to COVID-19 showing a decline in deaths following vaccination campaigns. “We were well aware of the short-term profile of Covid vaccines in terms of benefits and risks; conversely, their long-term benefit had never been studied,” Zureik explained.This new research provides crucial evidence to counter these narratives and reinforce public trust in vaccine safety.
